Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
Bladder, |
NA |
|
|
|
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
J82 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
tumCV↓, selectivity↑, TumCMig↓, EMT↓, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, STEAP3↓, Bax:Bcl2↑, cl‑Casp3↑,
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GPx1↓, 1, HO-1↓, 1, HO-1↑, 1, NRF2↓, 1, NRF2↑, 1, p‑NRF2↑, 1, ROS↑, 3, SOD2↓, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
STEAP3↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 2,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 2, Apoptosis↑, 1, Bax:Bcl2↑, 4, Casp3↑, 2, cl‑Casp3↑, 1, Casp8∅, 2, Casp9↑, 2, Cyt‑c↑, 2, DR5↑, 1, p27/CDKN1B↑, 1, TRAIL↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
HER2/EBBR2↓, 1, p70S6↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
cl‑PARP↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, cycA1/CCNA1↓, 1, cycD1/CCND1↓, 1, p19↑, 1, P21↑, 2, TumCCA?, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CD44↓, 1, CSCs↓, 1, EMT↓, 2, HDAC↓, 1, p‑mTOR↓, 2, p‑PI3K↓, 1,
Migration(tgid=13) ⓘ
TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, IKKα↓, 1, NF-kB↓, 1, NF-kB↑, 1, p65↓, 1, p‑p65↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, eff↓, 3, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, GutMicro↝, 1, HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, TumVol↓, 1, TumW↓, 2,
Total Targets: 59
Pathway results for Effect on Normal Cells:
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:352 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page